To be announced February 26.
To be announced February 25, 2021.
Featured Keynote Speakers Jill Barnholtz-Sloan Case Western Reserve University & University Hospitals of Cleveland Sex matters: Studying sex differences in cancer Dr. Barnholtz-Sloan is multi-disciplinary
Featured Keynote Speakers Jorgen de Jonge National Institute of Public Health and the Environment The ferret as a model to unravel broadly protective immune responses
Featured Keynote Speakers Gerrit Noordergraaf Chair, Residency & Research programs of Elisabeth-Tweesteden Hospital Multimodal Pain Therapy: now available for all your surgical needs Dr. Noordergraaf
Featured Keynote Speakers Daniel Nieto University of Santiago de Compostela Bioprinting a tumour microenvironment on-a-chip Dr. Daniel Nieto works with 3D cancer models and bioprinting
Featured Keynote Speakers Jaakko Tuomilehto National Institute for Health and Welfare Diabetes and risk coronary heart disease Dr. Tuomilehto has coordinated numerous scientific research projects,
Featured Keynote Speakers Irene Ghobrial Dana Farber Cancer Institute and Harvard University Dr. Ghobrial is a physician scientist who specializes in the field of Multiple
Featured Keynote Speakers Robert Weinberg Director of the MIT Ludwig Center The role of the cannabinoid receptor CB2 in the innate immune system on immune
Featured Keynote Speakers Kelly Sullivan, M.D., Ph.D. Georgia Southern University Evaluating evidence: considerations for clinical decision making Dr. Sullivan is a nationally recognized expert in